The cholesteryl ester transfer protein inhibitor anacetrapib reduces mortality from <em>Streptococcus pneumoniae</em>-induced sepsis in mice by enhancing monocyte activation, improving bacterial clearance, and reducing organ injury. This evidence concerns the gene CETP and Sepsis.